Home > Boards > Free Zone > Health and Sciences > Biotech Values

$ARFXF on fire after biogen news

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Gbathat Member Profile
 
Followed By 10
Posts 1,330
Boards Moderated 0
Alias Born 06/05/07
160x600 placeholder
Belgium Business Confidence Falls in September
Business sentiment in Belgium declined in September for the second consecutive month, after reaching a record high level in July.
Top Company News of the Day
Wheat Climbs on Indications of Tighter Supply -- Daily Grain Highlights
Front Month Nymex Natural Gas Rose 0.69% This Week to Settle at $5.1400 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 0.75% This Week to Settle at $2.1875 -- Data Talk
Costco On Pace for Record High Close -- Data Talk
United Airlines Fined $1.9 Million for Violating Transportation Department's Tarmac-Delay Rule
California Attorney General Appeals Purdue Pharma's Sackler Settlement
2Q GDP Still Seen +6.6% -- Data Week Ahead
Italy to Launch Three New Government Bonds in 4Q
DAX Ends the Week 0.27% Higher at 15531.75 -- Data Talk
CAC 40 Index Ends the Week 1.04% Higher at 6638.46 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.82% Higher at 3550.35 -- Data Talk
EURO STOXX 50 Index Ends the Week 0.67% Higher at 4158.51 -- Data Talk
STOXX Europe 600 Index Ends the Week 0.31% Higher at 463.29 -- Data Talk
FTSE 100 Index Ends the Week 1.26% Higher at 7051.48 -- Data Talk
Nike Down After Revenue Miss, Supply Chain Issues
Kansas City Fed Services Activity Index Slips But Stays Positive in September
VC Daily: Question: What to Make of Efforts in Congress to Lower Drug Prices?
Turkish Lira Falls Near Record Lows After Rate Cut; Norges Bank Raises Rates; Purchasing Managers Point to Slowing in U.S. and Europe
U.S. New Home Sales Rose in August
Rite Aid Expands Partnership With Uber
Salesforce.com on Track for Record High Close -- Data Talk
Nike Down Over 6%, on Pace For Largest Percent Decrease Since June 2020 -- Data Talk
Walgreens Rolls Out More Pfizer Booster Shots
Moderna to Supply Covid-19 Vaccine Doses in Peru
Petrofac Shares Rise on Guilty Plea to Seven Counts of Bribery
WPP to Pay $19 Million to Resolve SEC Charges of Anti-Bribery, Accounting Provisions
Gbathat   Monday, 06/07/21 02:01:02 PM
Re: None
Post # of 239688 
$ARFXF on fire after biogen news

still a long way to run

ProMIS Neurosciences makes a more selective and specific antibody than Biogen's aducanumab. Aducanumab is limited by brain swelling effects but has shown some clinical benefit, hence FDA approval today and a boost in their market cap by about $10-15 BILLION in just an hour.

ARFXF (ProMIS) makes PMN310 which can be dosed at higher levels. The company has been pre-phase I for a while, and shareholders were told that PHI funding was contingent on FDA approval of aducanumab.

Here's the real kicker... PMN's market cap is only $60M... which is peanuts compared to the market opportunity.

$ARFXF

glta

God grant me the serenity to deal with the things I cannot change; courage to change the things I can and should; and wisdom to know the difference.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences